Fawad, A.
Nilsson, P. M.
Struck, J.
Bergmann, A.
Melander, O.
Bennet, L.
Funding for this research was provided by:
Crafoordska Stiftelsen
Article History
Received: 24 October 2018
Accepted: 5 September 2019
First Online: 20 September 2019
Competing Interests
: J.S. is employed by Sphingotec GmbH, a company having patent rights in the proneurotensin assay and commercializing it. A.B. is CEO of Sphingotec GmbH and holds shares in this company. The other authors declare that they have neither disclosures nor financial or non-financial competing interests.